FB PHARMTECH LTD

💤Zombieactive
SC753069 · ltd · incorporated 2022-12-14
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Dec 2024
Net worth
£66.0k
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Technical testing and analysis
Sector: Professional, scientific & technical
ALSO REGISTERED FOR
  • 74909Other professional, scientific and technical activities n.e.c.
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.

Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: medium (76/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 2 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
6 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £65,985
Cash YoY
-15%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£59k
↓ 15% YoY
Net Worth
£66k
↑ 77% YoY
Current Assets
£114k
↑ 23% YoY
Current Liabilities
£0£23k£46k£69k£92k£114kDec 2023Dec 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-12-312023-12-31
Total assets£66.3k£37.4k
Current assets£114.5k£93.3k
Cash£58.8k£69.5k
Debtors£55.6k£23.8k
Net assets£66.0k£37.2k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (5 events)Click to expand
  1. 2025-04-25
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2024-09-12
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2022-12-14
    🏢
    Company incorporated
    As FB PHARMTECH LTD
  4. 2022-12-14
    SMITH, Oliver Charles appointed
    director
  5. 2022-12-14
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

75/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mr Oliver Charles Smith
Individual · British · DOB 11/1979 · age 47
75100%
75–100%board control75-100% shares · 75-100% voting · board control14/12/2022

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · EH postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
FARRER MARKETING LIMITED
SC546449 · est 2016 · no financials extracted
9y
FARRPOINT LIMITED
SC296299 · est 2006 · no financials extracted
20y
FAST ACTION PAY LIMITED
SC739139 · est 2022 · no financials extracted
3y
FAYYAN CARS LTD
SC815933 · est 2024 · no financials extracted
1y
FB ACTUARIAL AND BUSINESS CONSULTING LTD
SC695658 · est 2021 · no financials extracted
5y
FERGUSSON LAW & CO (EDINBURGH) LTD
SC744888 · est 2022 · no financials extracted
3y
FERLIEHALD LTD
SC771415 · est 2023 · no financials extracted
2y
FINALTY SERVICES LIMITED
SC416514 · est 2012 · no financials extracted
14y
FINOPSYS LIMITED
SC778277 · est 2023 · no financials extracted
2y
FINTEC RECRUIT LTD
SC864286 · est 2025 · no financials extracted
FIONA HARVEY CONSULTING LIMITED
SC871813 · est 2025 · no financials extracted
FÌOR FINANCIAL LTD
SC853511 · est 2025 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2022-12-14
Jurisdictionscotland
Primary SIC71200 — Technical testing and analysis

Registered office

9 Ainslie Place
Edinburgh
EH3 6AT
Scotland

Filing status

Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2026-12-27
Last: 2025-12-13

Officers (1 active · 0 resigned)

SMITH, Oliver Charles
director · ~47y · appointed 2022-12-14
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (6 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2025-12-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-04-25
confirmation-statement-with-updates
confirmation-statement · CS01
2024-12-17
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-09-12
confirmation-statement-with-updates
confirmation-statement · CS01
2023-12-15
incorporation-company
incorporation · NEWINC
2022-12-14